ADHD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- A parent or guardian must sign and date a consent form on behalf of their child
- The child must be willing to follow all study procedures and be available for the full length of the study
- Children of any gender aged 6 to 17 years old
- Children who have never taken stimulant medication, or who are willing to stop taking stimulant medication for about 3 days before the testing sessions
- For the ADHD group: children who have been diagnosed with ADHD based on a structured interview and who score high enough on an ADHD rating scale for their age and gender
- For the control group: children with no diagnosable condition based on a structured interview, and who score within the typical range on the ADHD rating scale for their age and gender
Who may not be able to join:
- Children currently taking psychiatric medications that cannot be stopped for approximately 3 days before testing
- Children with a current seizure disorder (a past history of fever-related seizures is allowed)
- Children who have certain medical devices implanted, such as a cardiac pacemaker, that could interfere with the monitoring equipment used in the study
- Children whose IQ is estimated by a clinician to be below 70
- Children who currently meet the full diagnostic criteria for PTSD, generalised anxiety disorder, major depression, or who have ever been diagnosed with autism spectrum disorder, bipolar disorder, or a psychotic disorder (children with milder anxiety or low mood symptoms that do not meet the full criteria for a disorder may still be considered)
- Children who are deaf or hard of hearing, as the study involves responding to sound-based tasks
- Children who are unable to complete the study assessments for any reason
- Children excluded for any other reason at the discretion of the principal investigator
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jeffrey Newcorn, MD Professor, Director, Division of ADHD and Learning Disorders Icahn School of Medicine at Mount Sinai
Phone: 212-659-8705
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Overall Agreement Rate (OAR) - probability that the test will be normal and the condition is normal or positive and the condition is positive, out of all subjects.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.